In the last 12 months, insiders at ARS Pharmaceuticals, Inc. ($SPRY) filed 447 transactions with the SEC: 10 open-market purchases totaling $51,242,890 and 221 sales totaling $121,119,253. Net insider sentiment: net selling.
ARS Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- RA CAPITAL MANAGEMENT, L.P. (Director) — 4 transactions totaling $31,433,526
- Lowenthal Richard E (PRESIDENT AND CEO) — 91 transactions totaling $24,378,324
- Tanimoto Sarina (CHIEF MEDICAL OFFICER) — 92 transactions totaling $24,357,734
- Flynn James E (TenPercentOwner) — 10 transactions totaling $23,806,856
- Thompson Peter A. (Director) — 7 transactions totaling $15,685,998
View all SEC Filings for ARS Pharmaceuticals, Inc. (SPRY).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Dorsey Brian | Chief Operating Officer | A | Stock option (right to buy) | 240000 | $0.00 | 240,000.0000 | 98,807,600 | 9999.99% | 0.24% |
| Jan. 2, 2026 | Chakma Justin | Chief Business Officer | A | Stock option (right to buy) | 240000 | $0.00 | 240,000.0000 | 98,807,600 | 9999.99% | 0.24% |
| Jan. 2, 2026 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | A | Stock option (right to buy) | 240000 | $0.00 | 240,000.0000 | 98,807,600 | 9999.99% | 0.24% |
| Jan. 2, 2026 | Lowenthal Richard E | PRESIDENT AND CEO | A | Stock Option (right to buy) | 240000 | $0.00 | 240,000.0000 | 98,807,600 | 9999.99% | 0.24% |
| Jan. 2, 2026 | Lowenthal Richard E | PRESIDENT AND CEO | A | Stock option (right to buy) | 875000 | $0.00 | 875,000.0000 | 98,807,600 | 9999.99% | 0.89% |
| Jan. 2, 2026 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 875000 | $0.00 | 875,000.0000 | 98,807,600 | 9999.99% | 0.89% |
| Jan. 2, 2026 | Scott Kathleen D. | Chief Financial Officer | A | Stock option (right to buy) | 240000 | $0.00 | 240,000.0000 | 98,807,600 | 9999.99% | 0.24% |
| Jan. 2, 2026 | Karas Eric | Chief Commercial Officer | A | Stock option (right to buy) | 240000 | $0.00 | 240,000.0000 | 98,807,600 | 9999.99% | 0.24% |
| Jan. 2, 2026 | Fitzpatrick Alexander A | Chief Legal Officer | A | Stock option (right to buy) | 240000 | $0.00 | 240,000.0000 | 98,807,600 | 9999.99% | 0.24% |
| Nov. 12, 2025 | Chakma Justin | Chief Business Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 89,047.0000 | 98,807,600 | 25.20% | 0.03% |
| Nov. 12, 2025 | Shah Pratik | Not found | G | Common Stock | 250000 | $0.00 | 4,574,554.0000 | 98,807,600 | 5.18% | 0.25% |
| Nov. 12, 2025 | Shah Pratik | Not found | G | Common Stock | 100000 | $0.00 | 4,474,554.0000 | 98,807,600 | 2.19% | 0.10% |
| Nov. 13, 2025 | Dorsey Brian | Chief Operating Officer | M | Common Stock | 21828 | $0.64 | 32,617.0000 | 98,807,600 | 202.32% | 0.02% |
| Nov. 13, 2025 | Dorsey Brian | Chief Operating Officer | S | Common Stock | 21828 | $8.71 | 10,789.0000 | 98,807,600 | 66.92% | 0.02% |
| Nov. 13, 2025 | Dorsey Brian | Chief Operating Officer | M | Stock Option (Right to Buy) | 21828 | $0.00 | 0.0000 | 98,807,600 | 100.00% | 0.02% |
| Nov. 12, 2025 | Chakma Justin | Chief Business Officer | M | Common Stock | 30000 | $0.84 | 166,380.0000 | 98,807,600 | 22.00% | 0.03% |
| Nov. 12, 2025 | Chakma Justin | Chief Business Officer | S | Common Stock | 30000 | $8.91 | 136,380.0000 | 98,807,600 | 18.03% | 0.03% |
| Nov. 12, 2025 | Chakma Justin | Chief Business Officer | S | Common Stock | 136380 | $8.86 | 0.0000 | 98,807,600 | 100.00% | 0.14% |
| Aug. 21, 2025 | Scott Kathleen D. | Chief Financial Officer | S | Common Stock | 12500 | $15.00 | 18,292.0000 | 102,390,828 | 40.59% | 0.01% |
| Aug. 21, 2025 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $14.49 | 11,303,141.0000 | 102,390,828 | 0.44% | 0.05% |
| Aug. 21, 2025 | Scott Kathleen D. | Chief Financial Officer | M | Common Stock | 12500 | $1.50 | 30,792.0000 | 102,390,828 | 68.34% | 0.01% |
| Aug. 21, 2025 | Scott Kathleen D. | Chief Financial Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 739,830.0000 | 102,390,828 | 1.66% | 0.01% |
| Aug. 20, 2025 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 37656 | $14.09 | 11,353,141.0000 | 102,390,828 | 0.33% | 0.04% |
| Aug. 19, 2025 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 12344 | $14.03 | 11,390,797.0000 | 102,390,828 | 0.11% | 0.01% |
| July 1, 2025 | Karas Eric | Chief Commercial Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 544,588.0000 | 102,390,828 | 2.68% | 0.01% |
| July 1, 2025 | Karas Eric | Chief Commercial Officer | S | Common Stock | 15000 | $16.99 | 10,315.0000 | 102,390,828 | 59.25% | 0.01% |
| July 1, 2025 | Karas Eric | Chief Commercial Officer | M | Common Stock | 15000 | $1.50 | 25,315.0000 | 102,390,828 | 145.42% | 0.01% |
| June 27, 2025 | Flynn James E | TenPercentOwner | S | Class A Common Stock | 370074 | $18.46 | 9,774,508.0000 | 102,390,828 | 3.65% | 0.36% |
| June 27, 2025 | Flynn James E | TenPercentOwner | S | Class A Common Stock | 370075 | $18.46 | 9,774,508.0000 | 102,390,828 | 3.65% | 0.36% |
| June 25, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 25, 2025 | Kelly Michael | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 25, 2025 | Shah Pratik | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 25, 2025 | Dadoo Rajeev | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 25, 2025 | Shawver Laura | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 25, 2025 | SCHNEIDER PHILLIP M | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 25, 2025 | SAUNDERS BRENT L | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 25, 2025 | Thompson Peter A. | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 25, 2025 | Islam Saqib | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 18, 2025 | Karas Eric | Chief Commercial Officer | S | Common Stock | 15000 | $16.00 | 7,696.0000 | 102,390,828 | 66.09% | 0.01% |
| June 18, 2025 | Karas Eric | Chief Commercial Officer | M | Common Stock | 15000 | $1.50 | 22,696.0000 | 102,390,828 | 194.91% | 0.01% |
| June 18, 2025 | Karas Eric | Chief Commercial Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 559,588.0000 | 102,390,828 | 2.61% | 0.01% |
| May 20, 2025 | SAUNDERS BRENT L | Not found | M | Common Stock | 120000 | $1.01 | 120,000.0000 | 102,390,828 | 9999.99% | 0.12% |
| May 20, 2025 | SAUNDERS BRENT L | Not found | S | Common Stock | 120000 | $14.25 | 0.0000 | 102,390,828 | 100.00% | 0.12% |
| May 20, 2025 | SAUNDERS BRENT L | Not found | M | Stock Option (Right to Buy) | 120000 | $0.00 | 470,950.0000 | 102,390,828 | 20.31% | 0.12% |
| May 20, 2025 | Scott Kathleen D. | Chief Financial Officer | M | Common Stock | 50000 | $1.50 | 65,674.0000 | 102,390,828 | 319.00% | 0.05% |
| May 20, 2025 | Scott Kathleen D. | Chief Financial Officer | S | Common Stock | 50000 | $14.10 | 15,674.0000 | 102,390,828 | 76.13% | 0.05% |
| May 20, 2025 | Scott Kathleen D. | Chief Financial Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 752,330.0000 | 102,390,828 | 6.23% | 0.05% |
| May 20, 2025 | Fitzpatrick Alexander A | Chief Legal Officer | M | Common Stock | 100000 | $5.58 | 192,582.0000 | 102,390,828 | 108.01% | 0.10% |
| May 20, 2025 | Fitzpatrick Alexander A | Chief Legal Officer | S | Common Stock | 102969 | $14.10 | 89,613.0000 | 102,390,828 | 53.47% | 0.10% |
| May 20, 2025 | Fitzpatrick Alexander A | Chief Legal Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 200,000.0000 | 102,390,828 | 33.33% | 0.10% |
| April 7, 2025 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 22509 | $0.00 | 51,555.0000 | 102,390,828 | 30.39% | 0.02% |
| April 7, 2025 | Shawver Laura | Not found | S | Common Stock | 50002 | $12.30 | 210,346.0000 | 102,390,828 | 19.21% | 0.05% |
| April 7, 2025 | Shawver Laura | Not found | M | Common Stock | 22509 | $4.85 | 232,855.0000 | 102,390,828 | 10.70% | 0.02% |
| April 7, 2025 | Shawver Laura | Not found | M | Common Stock | 27493 | $4.85 | 260,348.0000 | 102,390,828 | 11.81% | 0.03% |
| April 7, 2025 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 27493 | $0.00 | 24,062.0000 | 102,390,828 | 53.33% | 0.03% |
| March 20, 2025 | Karas Eric | Chief Commercial Officer | S | Common Stock | 10000 | $14.00 | 7,696.0000 | 102,390,828 | 56.51% | 0.01% |
| March 20, 2025 | Karas Eric | Chief Commercial Officer | M | Common Stock | 10000 | $1.50 | 17,696.0000 | 102,390,828 | 129.94% | 0.01% |
| March 20, 2025 | Karas Eric | Chief Commercial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 574,588.0000 | 102,390,828 | 1.71% | 0.01% |
| March 5, 2025 | Shawver Laura | Not found | S | Common Stock | 400 | $11.00 | 210,346.0000 | 102,390,828 | 0.19% | 0.00% |
| March 5, 2025 | Shawver Laura | Not found | M | Common Stock | 400 | $4.85 | 210,746.0000 | 102,390,828 | 0.19% | 0.00% |
| March 5, 2025 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 400 | $0.00 | 123,664.0000 | 102,390,828 | 0.32% | 0.00% |
| March 6, 2025 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 49600 | $0.00 | 74,064.0000 | 102,390,828 | 40.11% | 0.05% |
| March 6, 2025 | Shawver Laura | Not found | S | Common Stock | 49600 | $11.21 | 210,346.0000 | 102,390,828 | 19.08% | 0.05% |
| March 6, 2025 | Shawver Laura | Not found | M | Common Stock | 49600 | $4.85 | 259,946.0000 | 102,390,828 | 23.58% | 0.05% |
| Feb. 3, 2025 | Shawver Laura | Not found | M | Common Stock | 40936 | $4.85 | 260,346.0000 | 102,390,828 | 18.66% | 0.04% |
| Feb. 3, 2025 | Shawver Laura | Not found | S | Common Stock | 50000 | $12.31 | 210,346.0000 | 102,390,828 | 19.21% | 0.05% |
| Feb. 3, 2025 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 9064 | $0.00 | 0.0000 | 102,390,828 | 100.00% | 0.01% |
| Feb. 3, 2025 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 40936 | $0.00 | 124,064.0000 | 102,390,828 | 24.81% | 0.04% |
| Feb. 3, 2025 | Shawver Laura | Not found | M | Common Stock | 9064 | $3.15 | 219,410.0000 | 102,390,828 | 4.31% | 0.01% |
| Jan. 6, 2025 | Shawver Laura | Not found | S | Common Stock | 50000 | $11.10 | 210,346.0000 | 102,390,828 | 19.21% | 0.05% |
| Jan. 6, 2025 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 50000 | $0.00 | 9,064.0000 | 102,390,828 | 84.65% | 0.05% |
| Jan. 6, 2025 | Shawver Laura | Not found | M | Common Stock | 50000 | $3.15 | 260,346.0000 | 102,390,828 | 23.77% | 0.05% |
| Jan. 2, 2025 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | A | Stock option (right to buy) | 261900 | $0.00 | 261,900.0000 | 102,390,828 | 9999.99% | 0.26% |
| Jan. 2, 2025 | Dorsey Brian | Chief Operating Officer | A | Stock option (right to buy) | 261900 | $0.00 | 261,900.0000 | 102,390,828 | 9999.99% | 0.26% |
| Jan. 2, 2025 | Fitzpatrick Alexander A | Chief Legal Officer | A | Stock option (right to buy) | 152300 | $0.00 | 152,300.0000 | 102,390,828 | 9999.99% | 0.15% |
| Jan. 2, 2025 | Karas Eric | Chief Commercial Officer | A | Stock option (right to buy) | 152300 | $0.00 | 152,300.0000 | 102,390,828 | 9999.99% | 0.15% |
| Jan. 2, 2025 | Scott Kathleen D. | Chief Financial Officer | A | Stock option (right to buy) | 176700 | $0.00 | 176,700.0000 | 102,390,828 | 9999.99% | 0.17% |
| Jan. 2, 2025 | Chakma Justin | Chief Business Officer | A | Stock option (right to buy) | 274100 | $0.00 | 274,100.0000 | 102,390,828 | 9999.99% | 0.27% |
| Jan. 2, 2025 | Lowenthal Richard E | PRESIDENT AND CEO | A | Stock Option (right to buy) | 261900 | $0.00 | 261,900.0000 | 102,390,828 | 9999.99% | 0.26% |
| Jan. 2, 2025 | Lowenthal Richard E | PRESIDENT AND CEO | A | Stock option (right to buy) | 767600 | $0.00 | 767,600.0000 | 102,390,828 | 9999.99% | 0.75% |
| Jan. 2, 2025 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 767600 | $0.00 | 767,600.0000 | 102,390,828 | 9999.99% | 0.75% |
| Dec. 17, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $11.67 | 11,403,141.0000 | 97,032,331 | 0.44% | 0.05% |
| Dec. 17, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $11.67 | 11,403,141.0000 | 97,032,331 | 0.44% | 0.05% |
| Dec. 17, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.67 | 11,403,141.0000 | 97,032,331 | 0.44% | 0.05% |
| Dec. 17, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.67 | 11,403,141.0000 | 97,032,331 | 0.44% | 0.05% |
| Dec. 12, 2024 | Chakma Justin | Chief Business Officer | M | Common Stock | 117333 | $0.84 | 253,713.0000 | 97,032,331 | 86.03% | 0.12% |
| Dec. 13, 2024 | Chakma Justin | Chief Business Officer | M | Common Stock | 27272 | $1.44 | 163,652.0000 | 97,032,331 | 20.00% | 0.03% |
| Dec. 13, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 27272 | $12.06 | 136,380.0000 | 97,032,331 | 16.66% | 0.03% |
| Dec. 12, 2024 | Chakma Justin | Chief Business Officer | M | Stock Option (Right to Buy) | 117333 | $0.00 | 119,047.0000 | 97,032,331 | 49.64% | 0.12% |
| Dec. 13, 2024 | Chakma Justin | Chief Business Officer | M | Stock Option (Right to Buy) | 27272 | $0.00 | 55,461.0000 | 97,032,331 | 32.96% | 0.03% |
| Dec. 11, 2024 | Dorsey Brian | Chief Operating Officer | M | Common Stock | 15000 | $0.64 | 21,024.0000 | 97,032,331 | 249.00% | 0.02% |
| Dec. 11, 2024 | Dorsey Brian | Chief Operating Officer | S | Common Stock | 15000 | $12.43 | 6,024.0000 | 97,032,331 | 71.35% | 0.02% |
| Dec. 12, 2024 | Dorsey Brian | Chief Operating Officer | M | Common Stock | 25000 | $0.64 | 31,024.0000 | 97,032,331 | 415.01% | 0.03% |
| Dec. 12, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 117333 | $12.27 | 136,380.0000 | 97,032,331 | 46.25% | 0.12% |
| Dec. 12, 2024 | Dorsey Brian | Chief Operating Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 21,828.0000 | 97,032,331 | 53.39% | 0.03% |
| Dec. 11, 2024 | Dorsey Brian | Chief Operating Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 46,828.0000 | 97,032,331 | 24.26% | 0.02% |
| Dec. 12, 2024 | Dorsey Brian | Chief Operating Officer | S | Common Stock | 25000 | $12.30 | 6,024.0000 | 97,032,331 | 80.58% | 0.03% |
| Dec. 10, 2024 | Chakma Justin | Chief Business Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 97,032,331 | 100.00% | 0.05% |
| Dec. 10, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 50000 | $13.15 | 136,380.0000 | 97,032,331 | 26.83% | 0.05% |
| Dec. 10, 2024 | Chakma Justin | Chief Business Officer | M | Common Stock | 50000 | $0.84 | 186,380.0000 | 97,032,331 | 36.66% | 0.05% |
| Dec. 10, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.16 | 11,503,141.0000 | 97,032,331 | 0.43% | 0.05% |
| Dec. 10, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $13.17 | 11,503,141.0000 | 97,032,331 | 0.43% | 0.05% |
| Dec. 10, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.17 | 11,503,141.0000 | 97,032,331 | 0.43% | 0.05% |
| Dec. 10, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $13.16 | 11,503,141.0000 | 97,032,331 | 0.43% | 0.05% |
| Dec. 6, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Common Stock | 13789 | $1.44 | 11,591,265.0000 | 97,032,331 | 0.12% | 0.01% |
| Dec. 6, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Stock Option (right to buy) | 11876 | $0.00 | 1,426,248.0000 | 97,032,331 | 0.83% | 0.01% |
| Dec. 6, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Stock Option (right to buy) | 11876 | $0.00 | 1,426,248.0000 | 97,032,331 | 0.83% | 0.01% |
| Dec. 6, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 11876 | $8.42 | 11,603,141.0000 | 97,032,331 | 0.10% | 0.01% |
| Dec. 6, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 13789 | $1.44 | 11,591,265.0000 | 97,032,331 | 0.12% | 0.01% |
| Dec. 6, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 11876 | $8.42 | 11,603,141.0000 | 97,032,331 | 0.10% | 0.01% |
| Dec. 6, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 11876 | $0.00 | 1,426,248.0000 | 97,032,331 | 0.83% | 0.01% |
| Dec. 6, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 13789 | $0.00 | 1,108,808.0000 | 97,032,331 | 1.23% | 0.01% |
| Dec. 6, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 11876 | $0.00 | 1,426,248.0000 | 97,032,331 | 0.83% | 0.01% |
| Dec. 6, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Common Stock | 11876 | $8.42 | 11,603,141.0000 | 97,032,331 | 0.10% | 0.01% |
| Dec. 6, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Common Stock | 11876 | $8.42 | 11,603,141.0000 | 97,032,331 | 0.10% | 0.01% |
| Dec. 6, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Stock Option (right to buy) | 13789 | $0.00 | 1,108,808.0000 | 97,032,331 | 1.23% | 0.01% |
| Dec. 6, 2024 | Chakma Justin | Chief Business Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 97,032,331 | 50.00% | 0.05% |
| Dec. 5, 2024 | Chakma Justin | Chief Business Officer | M | Stock Option (Right to Buy) | 49640 | $0.00 | 100,000.0000 | 97,032,331 | 33.17% | 0.05% |
| Dec. 4, 2024 | Chakma Justin | Chief Business Officer | M | Stock Option (Right to Buy) | 45000 | $0.00 | 149,640.0000 | 97,032,331 | 23.12% | 0.05% |
| Dec. 6, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 50000 | $14.23 | 136,380.0000 | 97,032,331 | 26.83% | 0.05% |
| Dec. 6, 2024 | Chakma Justin | Chief Business Officer | M | Common Stock | 50000 | $0.84 | 186,380.0000 | 97,032,331 | 36.66% | 0.05% |
| Dec. 5, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 49640 | $14.13 | 136,380.0000 | 97,032,331 | 26.69% | 0.05% |
| Dec. 5, 2024 | Chakma Justin | Chief Business Officer | M | Common Stock | 49640 | $0.84 | 186,020.0000 | 97,032,331 | 36.40% | 0.05% |
| Dec. 4, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 45000 | $13.95 | 136,380.0000 | 97,032,331 | 24.81% | 0.05% |
| Dec. 4, 2024 | Chakma Justin | Chief Business Officer | M | Common Stock | 45000 | $0.84 | 181,380.0000 | 97,032,331 | 33.00% | 0.05% |
| Dec. 2, 2024 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 67616 | $0.00 | 0.0000 | 97,032,331 | 100.00% | 0.07% |
| Dec. 2, 2024 | Chakma Justin | Chief Business Officer | M | Common Stock | 45000 | $0.84 | 181,380.0000 | 97,032,331 | 33.00% | 0.05% |
| Dec. 2, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 45000 | $13.67 | 136,380.0000 | 97,032,331 | 24.81% | 0.05% |
| Dec. 3, 2024 | Chakma Justin | Chief Business Officer | M | Common Stock | 3260 | $0.84 | 139,640.0000 | 97,032,331 | 2.39% | 0.00% |
| Dec. 3, 2024 | Chakma Justin | Chief Business Officer | M | Common Stock | 41740 | $0.84 | 181,380.0000 | 97,032,331 | 29.89% | 0.04% |
| Dec. 3, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 45000 | $13.19 | 136,380.0000 | 97,032,331 | 24.81% | 0.05% |
| Dec. 2, 2024 | Chakma Justin | Chief Business Officer | M | Stock Option (Right to Buy) | 45000 | $0.00 | 3,260.0000 | 97,032,331 | 93.24% | 0.05% |
| Dec. 3, 2024 | Chakma Justin | Chief Business Officer | M | Stock Option (Right to Buy) | 3260 | $0.00 | 0.0000 | 97,032,331 | 100.00% | 0.00% |
| Dec. 3, 2024 | Chakma Justin | Chief Business Officer | M | Stock Option (Right to Buy) | 41740 | $0.00 | 194,640.0000 | 97,032,331 | 17.66% | 0.04% |
| Dec. 2, 2024 | Shawver Laura | Not found | M | Common Stock | 67616 | $1.27 | 277,962.0000 | 97,032,331 | 32.15% | 0.07% |
| Dec. 2, 2024 | Shawver Laura | Not found | M | Common Stock | 29628 | $1.27 | 307,590.0000 | 97,032,331 | 10.66% | 0.03% |
| Dec. 2, 2024 | Shawver Laura | Not found | S | Common Stock | 96343 | $13.55 | 211,247.0000 | 97,032,331 | 31.32% | 0.10% |
| Dec. 2, 2024 | Shawver Laura | Not found | S | Common Stock | 901 | $14.34 | 210,346.0000 | 97,032,331 | 0.43% | 0.00% |
| Dec. 3, 2024 | Shawver Laura | Not found | M | Common Stock | 25606 | $1.27 | 235,952.0000 | 97,032,331 | 12.17% | 0.03% |
| Dec. 3, 2024 | Shawver Laura | Not found | M | Common Stock | 62378 | $3.15 | 298,330.0000 | 97,032,331 | 26.44% | 0.06% |
| Dec. 3, 2024 | Shawver Laura | Not found | S | Common Stock | 87984 | $13.26 | 210,346.0000 | 97,032,331 | 29.49% | 0.09% |
| Dec. 4, 2024 | Shawver Laura | Not found | M | Common Stock | 14772 | $3.15 | 225,118.0000 | 97,032,331 | 7.02% | 0.02% |
| Dec. 4, 2024 | Shawver Laura | Not found | S | Common Stock | 14772 | $13.75 | 210,346.0000 | 97,032,331 | 6.56% | 0.02% |
| Dec. 2, 2024 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 29628 | $0.00 | 25,606.0000 | 97,032,331 | 53.64% | 0.03% |
| Dec. 3, 2024 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 25606 | $0.00 | 0.0000 | 97,032,331 | 100.00% | 0.03% |
| Dec. 3, 2024 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 62378 | $0.00 | 73,836.0000 | 97,032,331 | 45.79% | 0.06% |
| Dec. 4, 2024 | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 14772 | $0.00 | 59,064.0000 | 97,032,331 | 20.01% | 0.02% |
| Dec. 2, 2024 | Karas Eric | Chief Commercial Officer | M | Common Stock | 3717 | $1.50 | 9,410.0000 | 97,032,331 | 65.29% | 0.00% |
| Dec. 2, 2024 | Karas Eric | Chief Commercial Officer | S | Common Stock | 3717 | $14.11 | 5,693.0000 | 97,032,331 | 39.50% | 0.00% |
| Dec. 4, 2024 | Karas Eric | Chief Commercial Officer | M | Common Stock | 6283 | $1.50 | 11,976.0000 | 97,032,331 | 110.36% | 0.01% |
| Dec. 4, 2024 | Karas Eric | Chief Commercial Officer | S | Common Stock | 6283 | $14.00 | 5,693.0000 | 97,032,331 | 52.46% | 0.01% |
| Dec. 2, 2024 | Karas Eric | Chief Commercial Officer | M | Stock Option (Right to Buy) | 3717 | $0.00 | 590,871.0000 | 97,032,331 | 0.63% | 0.00% |
| Dec. 4, 2024 | Karas Eric | Chief Commercial Officer | M | Stock Option (Right to Buy) | 6283 | $0.00 | 584,588.0000 | 97,032,331 | 1.06% | 0.01% |
| Nov. 27, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 25000 | $14.39 | 136,380.0000 | 97,032,331 | 15.49% | 0.03% |
| Nov. 26, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 42186 | $14.05 | 161,380.0000 | 97,032,331 | 20.72% | 0.04% |
| Nov. 25, 2024 | Chakma Justin | Chief Business Officer | S | Common Stock | 32814 | $14.00 | 203,566.0000 | 97,032,331 | 13.88% | 0.03% |
| Nov. 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $13.95 | 11,565,600.0000 | 97,032,331 | 0.43% | 0.05% |
| Nov. 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $13.95 | 11,565,600.0000 | 97,032,331 | 0.43% | 0.05% |
| Nov. 19, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.95 | 11,565,600.0000 | 97,032,331 | 0.43% | 0.05% |
| Nov. 19, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.95 | 11,565,600.0000 | 97,032,331 | 0.43% | 0.05% |
| Nov. 12, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 45045 | $16.76 | 11,670,555.0000 | 97,032,331 | 0.38% | 0.05% |
| Nov. 12, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 4876 | $17.64 | 12,967,049.0000 | 97,032,331 | 0.04% | 0.01% |
| Nov. 12, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 45124 | $16.76 | 12,971,925.0000 | 97,032,331 | 0.35% | 0.05% |
| Nov. 12, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 4955 | $17.64 | 12,967,049.0000 | 97,032,331 | 0.04% | 0.01% |
| Nov. 12, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 4876 | $17.64 | 11,665,600.0000 | 97,032,331 | 0.04% | 0.01% |
| Nov. 12, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 45124 | $16.76 | 11,670,476.0000 | 97,032,331 | 0.39% | 0.05% |
| Nov. 12, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 45045 | $16.76 | 12,967,049.0000 | 97,032,331 | 0.35% | 0.05% |
| Nov. 12, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 4955 | $17.64 | 11,665,600.0000 | 97,032,331 | 0.04% | 0.01% |
| Nov. 11, 2024 | Flynn James E | TenPercentOwner | S | Class A Common Stock | 40596 | $17.45 | 10,755,696.0000 | 97,032,331 | 0.38% | 0.04% |
| Nov. 11, 2024 | Flynn James E | TenPercentOwner | S | Class A Common Stock | 223632 | $18.15 | 10,532,064.0000 | 97,032,331 | 2.08% | 0.23% |
| Nov. 12, 2024 | Flynn James E | TenPercentOwner | S | Class A Common Stock | 7853 | $17.16 | 10,524,211.0000 | 97,032,331 | 0.07% | 0.01% |
| Nov. 12, 2024 | Flynn James E | TenPercentOwner | S | Class A Common Stock | 7854 | $17.16 | 10,524,210.0000 | 97,032,331 | 0.07% | 0.01% |
| Nov. 12, 2024 | Flynn James E | TenPercentOwner | S | Class A Common Stock | 9554 | $17.77 | 10,514,657.0000 | 97,032,331 | 0.09% | 0.01% |
| Nov. 12, 2024 | Flynn James E | TenPercentOwner | S | Class A Common Stock | 9553 | $17.77 | 10,514,657.0000 | 97,032,331 | 0.09% | 0.01% |
| Nov. 11, 2024 | Flynn James E | TenPercentOwner | S | Class A Common Stock | 40596 | $17.45 | 10,755,696.0000 | 97,032,331 | 0.38% | 0.04% |
| Nov. 11, 2024 | Flynn James E | TenPercentOwner | S | Class A Common Stock | 223632 | $18.15 | 10,532,064.0000 | 97,032,331 | 2.08% | 0.23% |
| Oct. 15, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $14.88 | 11,765,600.0000 | 97,032,331 | 0.42% | 0.05% |
| Oct. 15, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1450 | $15.25 | 11,765,600.0000 | 97,032,331 | 0.01% | 0.00% |
| Oct. 15, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 48550 | $14.86 | 11,767,050.0000 | 97,032,331 | 0.41% | 0.05% |
| Oct. 15, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $14.88 | 11,765,600.0000 | 97,032,331 | 0.42% | 0.05% |
| Oct. 15, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 1450 | $15.25 | 11,765,600.0000 | 97,032,331 | 0.01% | 0.00% |
| Oct. 15, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 48550 | $14.86 | 11,767,050.0000 | 97,032,331 | 0.41% | 0.05% |
| Oct. 16, 2024 | Scott Kathleen D. | Chief Financial Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 802,330.0000 | 97,032,331 | 1.53% | 0.01% |
| Oct. 16, 2024 | Scott Kathleen D. | Chief Financial Officer | S | Common Stock | 12500 | $16.00 | 13,199.0000 | 97,032,331 | 48.64% | 0.01% |
| Oct. 16, 2024 | Scott Kathleen D. | Chief Financial Officer | M | Common Stock | 12500 | $1.50 | 25,699.0000 | 97,032,331 | 94.70% | 0.01% |
| Oct. 8, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $13.83 | 11,865,600.0000 | 97,032,331 | 0.42% | 0.05% |
| Oct. 8, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $13.83 | 11,865,600.0000 | 97,032,331 | 0.42% | 0.05% |
| Oct. 8, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.83 | 11,865,600.0000 | 97,032,331 | 0.42% | 0.05% |
| Oct. 8, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $13.83 | 11,865,600.0000 | 97,032,331 | 0.42% | 0.05% |
| Sept. 18, 2024 | Karas Eric | Chief Commercial Officer | S | Common Stock | 10000 | $14.00 | 5,693.0000 | 95,215,322 | 63.72% | 0.01% |
| Sept. 18, 2024 | Karas Eric | Chief Commercial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 594,588.0000 | 95,215,322 | 1.65% | 0.01% |
| Sept. 17, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $12.93 | 11,965,600.0000 | 95,215,322 | 0.42% | 0.05% |
| Sept. 17, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $12.93 | 11,965,600.0000 | 95,215,322 | 0.42% | 0.05% |
| Sept. 17, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $12.93 | 11,965,600.0000 | 95,215,322 | 0.42% | 0.05% |
| Sept. 17, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $12.93 | 11,965,600.0000 | 95,215,322 | 0.42% | 0.05% |
| Sept. 18, 2024 | Karas Eric | Chief Commercial Officer | M | Common Stock | 10000 | $1.50 | 15,693.0000 | 95,215,322 | 175.65% | 0.01% |
| Sept. 10, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $11.50 | 12,065,600.0000 | 95,215,322 | 0.41% | 0.05% |
| Sept. 10, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.50 | 12,065,600.0000 | 95,215,322 | 0.41% | 0.05% |
| Sept. 10, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.50 | 12,065,600.0000 | 95,215,322 | 0.41% | 0.05% |
| Sept. 10, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $11.50 | 12,065,600.0000 | 95,215,322 | 0.41% | 0.05% |
| Aug. 26, 2024 | Thompson Peter A. | Director | S | Common Stock | 83695 | $13.00 | 8,288,510.0000 | 95,215,322 | 1.00% | 0.09% |
| Aug. 26, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 83695 | $13.00 | 8,288,510.0000 | 95,215,322 | 1.00% | 0.09% |
| Aug. 21, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 13300 | $14.61 | 8,833,187.0000 | 95,215,322 | 0.15% | 0.01% |
| Aug. 21, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 394400 | $13.52 | 8,846,487.0000 | 95,215,322 | 4.27% | 0.41% |
| Aug. 23, 2024 | Thompson Peter A. | Director | S | Common Stock | 69500 | $13.03 | 8,372,205.0000 | 95,215,322 | 0.82% | 0.07% |
| Aug. 22, 2024 | Thompson Peter A. | Director | S | Common Stock | 391482 | $12.94 | 8,441,705.0000 | 95,215,322 | 4.43% | 0.41% |
| Aug. 21, 2024 | Thompson Peter A. | Director | S | Common Stock | 13300 | $14.61 | 8,833,187.0000 | 95,215,322 | 0.15% | 0.01% |
| Aug. 21, 2024 | Thompson Peter A. | Director | S | Common Stock | 394400 | $13.52 | 8,846,487.0000 | 95,215,322 | 4.27% | 0.41% |
| Aug. 23, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 69500 | $13.03 | 8,372,205.0000 | 95,215,322 | 0.82% | 0.07% |
| Aug. 22, 2024 | ORBIMED ADVISORS LLC | Director | S | Common Stock | 391482 | $12.94 | 8,441,705.0000 | 95,215,322 | 4.43% | 0.41% |
| Aug. 20, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 11523 | $15.62 | 12,167,861.0000 | 95,215,322 | 0.09% | 0.01% |
| Aug. 20, 2024 | Dorsey Brian | Chief Operating Officer | S | Common Stock | 50000 | $15.00 | 6,024.0000 | 95,215,322 | 89.25% | 0.05% |
| Aug. 20, 2024 | Dorsey Brian | Chief Operating Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 61,828.0000 | 95,215,322 | 44.71% | 0.05% |
| Aug. 19, 2024 | Karas Eric | Chief Commercial Officer | M | Common Stock | 10000 | $1.50 | 15,693.0000 | 95,215,322 | 175.65% | 0.01% |
| Aug. 19, 2024 | Karas Eric | Chief Commercial Officer | S | Common Stock | 10000 | $14.00 | 5,693.0000 | 95,215,322 | 63.72% | 0.01% |
| Aug. 19, 2024 | Karas Eric | Chief Commercial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 604,588.0000 | 95,215,322 | 1.63% | 0.01% |
| Aug. 20, 2024 | Scott Kathleen D. | Chief Financial Officer | M | Common Stock | 12500 | $1.50 | 25,699.0000 | 95,215,322 | 94.70% | 0.01% |
| Aug. 20, 2024 | Scott Kathleen D. | Chief Financial Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 814,830.0000 | 95,215,322 | 1.51% | 0.01% |
| Aug. 20, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 35944 | $14.76 | 12,179,656.0000 | 95,215,322 | 0.29% | 0.04% |
| Aug. 20, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 11756 | $15.61 | 12,167,900.0000 | 95,215,322 | 0.10% | 0.01% |
| Aug. 20, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 2300 | $16.26 | 12,165,600.0000 | 95,215,322 | 0.02% | 0.00% |
| Aug. 20, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 36216 | $14.76 | 12,179,384.0000 | 95,215,322 | 0.30% | 0.04% |
| Aug. 20, 2024 | Dorsey Brian | Chief Operating Officer | M | Common Stock | 50000 | $0.64 | 56,024.0000 | 95,215,322 | 830.01% | 0.05% |
| Aug. 20, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 2261 | $16.25 | 12,165,600.0000 | 95,215,322 | 0.02% | 0.00% |
| Aug. 20, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 35944 | $14.76 | 12,179,656.0000 | 95,215,322 | 0.29% | 0.04% |
| Aug. 20, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 11756 | $15.61 | 12,167,900.0000 | 95,215,322 | 0.10% | 0.01% |
| Aug. 20, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2300 | $16.26 | 12,165,600.0000 | 95,215,322 | 0.02% | 0.00% |
| Aug. 20, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 36216 | $14.76 | 12,179,384.0000 | 95,215,322 | 0.30% | 0.04% |
| Aug. 20, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 11523 | $15.62 | 12,167,861.0000 | 95,215,322 | 0.09% | 0.01% |
| Aug. 20, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2261 | $16.25 | 12,165,600.0000 | 95,215,322 | 0.02% | 0.00% |
| Aug. 20, 2024 | Scott Kathleen D. | Chief Financial Officer | S | Common Stock | 12500 | $16.00 | 13,199.0000 | 95,215,322 | 48.64% | 0.01% |
| Aug. 13, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 35363 | $12.77 | 12,265,600.0000 | 95,215,322 | 0.29% | 0.04% |
| Aug. 13, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 14637 | $11.77 | 12,300,963.0000 | 95,215,322 | 0.12% | 0.02% |
| Aug. 13, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 35401 | $12.76 | 12,265,600.0000 | 95,215,322 | 0.29% | 0.04% |
| Aug. 13, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 14599 | $11.78 | 12,301,001.0000 | 95,215,322 | 0.12% | 0.02% |
| Aug. 13, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 35363 | $12.77 | 13,747,495.0000 | 95,215,322 | 0.26% | 0.04% |
| Aug. 13, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 14637 | $11.77 | 13,782,858.0000 | 95,215,322 | 0.11% | 0.02% |
| Aug. 13, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 35401 | $12.76 | 13,747,495.0000 | 95,215,322 | 0.26% | 0.04% |
| Aug. 13, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 14599 | $11.78 | 13,747,495.0000 | 95,215,322 | 0.11% | 0.02% |
| Aug. 13, 2024 | Dorsey Brian | Chief Operating Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 111,828.0000 | 95,215,322 | 21.15% | 0.03% |
| Aug. 13, 2024 | Dorsey Brian | Chief Operating Officer | S | Common Stock | 30000 | $13.00 | 6,024.0000 | 95,215,322 | 83.28% | 0.03% |
| Aug. 13, 2024 | Dorsey Brian | Chief Operating Officer | M | Common Stock | 30000 | $0.64 | 36,024.0000 | 95,215,322 | 498.01% | 0.03% |
| July 16, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $11.40 | 12,365,600.0000 | 95,215,322 | 0.40% | 0.05% |
| July 16, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.40 | 12,365,600.0000 | 95,215,322 | 0.40% | 0.05% |
| July 16, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $11.40 | 12,365,600.0000 | 95,215,322 | 0.40% | 0.05% |
| July 16, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $11.40 | 12,365,600.0000 | 95,215,322 | 0.40% | 0.05% |
| July 9, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.62 | 12,465,600.0000 | 95,215,322 | 0.40% | 0.05% |
| July 9, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.62 | 12,465,600.0000 | 95,215,322 | 0.40% | 0.05% |
| July 9, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $9.62 | 12,465,600.0000 | 95,215,322 | 0.40% | 0.05% |
| July 9, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $9.62 | 12,465,600.0000 | 95,215,322 | 0.40% | 0.05% |
| June 20, 2024 | Islam Saqib | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 20, 2024 | SCHNEIDER PHILLIP M | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 20, 2024 | Shawver Laura | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 20, 2024 | SAUNDERS BRENT L | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 20, 2024 | Thompson Peter A. | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 20, 2024 | Kelly Michael | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 20, 2024 | Dadoo Rajeev | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 20, 2024 | Shah Pratik | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 20, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 13, 2024 | Shah Pratik | Not found | G | Common Stock | 1132900 | $0.00 | 4,824,554.0000 | 95,215,322 | 19.02% | 1.19% |
| June 13, 2024 | Shah Pratik | Not found | G | Common Stock | 200000 | $0.00 | 5,957,454.0000 | 95,215,322 | 3.25% | 0.21% |
| June 12, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 48028 | $9.14 | 12,565,600.0000 | 95,215,322 | 0.38% | 0.05% |
| June 12, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 47834 | $9.15 | 12,565,600.0000 | 95,215,322 | 0.38% | 0.05% |
| June 12, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 48028 | $9.14 | 12,565,600.0000 | 95,215,322 | 0.38% | 0.05% |
| June 11, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 2166 | $9.00 | 12,613,434.0000 | 95,215,322 | 0.02% | 0.00% |
| June 11, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 1972 | $9.00 | 12,613,628.0000 | 95,215,322 | 0.02% | 0.00% |
| June 12, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 47834 | $9.15 | 12,565,600.0000 | 95,215,322 | 0.38% | 0.05% |
| June 11, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2166 | $9.00 | 12,613,434.0000 | 95,215,322 | 0.02% | 0.00% |
| June 11, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1972 | $9.00 | 12,613,628.0000 | 95,215,322 | 0.02% | 0.00% |
| June 4, 2024 | Shah Pratik | Not found | J | Common Stock | 2665800 | $0.00 | 7,490,404.0000 | 95,215,322 | 26.25% | 2.80% |
| June 7, 2024 | Shah Pratik | Not found | G | Common Stock | 1332950 | $0.00 | 6,157,454.0000 | 95,215,322 | 17.80% | 1.40% |
| June 4, 2024 | Shah Pratik | Not found | J | Common Stock | 2665800 | $0.00 | 8,823,304.0000 | 95,215,322 | 23.20% | 2.80% |
| June 4, 2024 | Shah Pratik | Not found | G | Common Stock | 1332900 | $0.00 | 7,490,404.0000 | 95,215,322 | 15.11% | 1.40% |
| June 4, 2024 | Shah Pratik | Not found | G | Common Stock | 1332900 | $0.00 | 7,490,404.0000 | 95,215,322 | 21.65% | 1.40% |
| May 14, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2884 | $9.01 | 14,354,909.0000 | 95,215,322 | 0.02% | 0.00% |
| May 14, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 2873 | $9.01 | 12,712,727.0000 | 95,215,322 | 0.02% | 0.00% |
| May 14, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 2884 | $9.01 | 12,712,716.0000 | 95,215,322 | 0.02% | 0.00% |
| May 15, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 2381 | $9.05 | 12,710,346.0000 | 95,215,322 | 0.02% | 0.00% |
| May 15, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 2766 | $9.04 | 12,709,950.0000 | 95,215,322 | 0.02% | 0.00% |
| May 16, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 44746 | $9.06 | 12,665,600.0000 | 95,215,322 | 0.35% | 0.05% |
| May 16, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 44350 | $9.06 | 12,665,600.0000 | 95,215,322 | 0.35% | 0.05% |
| May 14, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2873 | $9.01 | 14,354,920.0000 | 95,215,322 | 0.02% | 0.00% |
| May 15, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2381 | $9.05 | 14,307,793.0000 | 95,215,322 | 0.02% | 0.00% |
| May 15, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 2766 | $9.04 | 14,352,143.0000 | 95,215,322 | 0.02% | 0.00% |
| May 16, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 44746 | $9.06 | 14,307,793.0000 | 95,215,322 | 0.31% | 0.05% |
| May 16, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 44350 | $9.06 | 14,307,793.0000 | 95,215,322 | 0.31% | 0.05% |
| May 7, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $9.34 | 12,765,600.0000 | 95,215,322 | 0.39% | 0.05% |
| May 7, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.34 | 12,765,600.0000 | 95,215,322 | 0.39% | 0.05% |
| May 7, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $9.34 | 12,765,600.0000 | 95,215,322 | 0.39% | 0.05% |
| May 7, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.34 | 12,765,600.0000 | 95,215,322 | 0.39% | 0.05% |
| April 23, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Common Stock | 48260 | $1.44 | 12,865,600.0000 | 95,215,322 | 0.38% | 0.05% |
| April 23, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Stock Option (right to buy) | 82733 | $0.00 | 0.0000 | 95,215,322 | 100.00% | 0.09% |
| April 23, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Stock Option (right to buy) | 48260 | $0.00 | 34,473.0000 | 95,215,322 | 58.33% | 0.05% |
| April 23, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 48260 | $0.00 | 34,473.0000 | 95,215,322 | 58.33% | 0.05% |
| April 23, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 82733 | $0.84 | 12,817,340.0000 | 95,215,322 | 0.65% | 0.09% |
| April 23, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 48260 | $1.44 | 12,865,600.0000 | 95,215,322 | 0.38% | 0.05% |
| April 23, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Common Stock | 82733 | $0.84 | 12,817,340.0000 | 95,215,322 | 0.65% | 0.09% |
| April 23, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 82733 | $0.00 | 0.0000 | 95,215,322 | 100.00% | 0.09% |
| April 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Common Stock | 69444 | $1.44 | 12,734,607.0000 | 95,215,322 | 0.55% | 0.07% |
| April 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Common Stock | 119047 | $0.84 | 12,665,163.0000 | 95,215,322 | 0.95% | 0.13% |
| April 19, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 69444 | $0.00 | 166,936.0000 | 95,215,322 | 29.38% | 0.07% |
| April 19, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 69444 | $1.44 | 12,734,607.0000 | 95,215,322 | 0.55% | 0.07% |
| April 19, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Common Stock | 119047 | $0.84 | 12,665,163.0000 | 95,215,322 | 0.95% | 0.13% |
| April 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Stock Option (right to buy) | 69444 | $0.00 | 166,936.0000 | 95,215,322 | 29.38% | 0.07% |
| April 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M | Stock Option (right to buy) | 119047 | $0.00 | 117,333.0000 | 95,215,322 | 50.36% | 0.13% |
| April 19, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | M | Stock Option (right to buy) | 119047 | $0.00 | 117,333.0000 | 95,215,322 | 50.36% | 0.13% |
| April 16, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.28 | 12,546,116.0000 | 95,215,322 | 0.40% | 0.05% |
| April 16, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.28 | 12,546,116.0000 | 95,215,322 | 0.40% | 0.05% |
| April 16, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $9.28 | 12,546,116.0000 | 95,215,322 | 0.40% | 0.05% |
| April 16, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $9.28 | 12,546,116.0000 | 95,215,322 | 0.40% | 0.05% |
| April 9, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.28 | 12,646,116.0000 | 95,215,322 | 0.39% | 0.05% |
| April 9, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 50000 | $9.28 | 12,646,116.0000 | 95,215,322 | 0.39% | 0.05% |
| April 9, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $9.28 | 12,646,116.0000 | 95,215,322 | 0.39% | 0.05% |
| April 9, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 50000 | $9.28 | 12,646,116.0000 | 95,215,322 | 0.39% | 0.05% |
| March 27, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 505954 | $9.79 | 10,860,977.0000 | 95,215,322 | 4.89% | 0.53% |
| March 26, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 457745 | $9.55 | 10,355,023.0000 | 95,215,322 | 4.62% | 0.48% |
| March 25, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 437600 | $9.06 | 9,897,278.0000 | 95,215,322 | 4.63% | 0.46% |
| March 25, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 47632 | $9.12 | 12,746,116.0000 | 95,215,322 | 0.37% | 0.05% |
| March 22, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1017 | $9.03 | 12,793,751.0000 | 95,215,322 | 0.01% | 0.00% |
| March 22, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1326 | $9.01 | 12,793,748.0000 | 95,215,322 | 0.01% | 0.00% |
| March 25, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 47635 | $9.12 | 12,746,116.0000 | 95,215,322 | 0.37% | 0.05% |
| March 22, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 1017 | $9.03 | 12,793,751.0000 | 95,215,322 | 0.01% | 0.00% |
| March 22, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 1326 | $9.01 | 12,793,748.0000 | 95,215,322 | 0.01% | 0.00% |
| March 25, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 47635 | $9.12 | 12,746,116.0000 | 95,215,322 | 0.37% | 0.05% |
| March 25, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 47632 | $9.12 | 12,746,116.0000 | 95,215,322 | 0.37% | 0.05% |
| March 21, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 100 | $9.00 | 12,843,726.0000 | 95,215,322 | 0.00% | 0.00% |
| March 19, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 976 | $9.03 | 12,844,098.0000 | 95,215,322 | 0.01% | 0.00% |
| March 19, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 942 | $9.04 | 12,843,826.0000 | 95,215,322 | 0.01% | 0.00% |
| March 21, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 372 | $9.00 | 12,843,726.0000 | 95,215,322 | 0.00% | 0.00% |
| March 21, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 100 | $9.00 | 12,843,726.0000 | 95,215,322 | 0.00% | 0.00% |
| March 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 976 | $9.03 | 12,844,098.0000 | 95,215,322 | 0.01% | 0.00% |
| March 19, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 942 | $9.04 | 12,843,826.0000 | 95,215,322 | 0.01% | 0.00% |
| March 21, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 372 | $9.00 | 12,843,726.0000 | 95,215,322 | 0.00% | 0.00% |
| March 15, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 48295 | $9.14 | 12,846,116.0000 | 95,215,322 | 0.37% | 0.05% |
| March 15, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 48461 | $9.14 | 12,846,116.0000 | 95,215,322 | 0.38% | 0.05% |
| March 14, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 239 | $9.00 | 12,894,577.0000 | 95,215,322 | 0.00% | 0.00% |
| March 14, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 205 | $9.00 | 12,894,411.0000 | 95,215,322 | 0.00% | 0.00% |
| March 13, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 1300 | $9.00 | 12,894,816.0000 | 95,215,322 | 0.01% | 0.00% |
| March 13, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 1500 | $9.00 | 12,894,616.0000 | 95,215,322 | 0.01% | 0.00% |
| March 15, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 48461 | $9.14 | 12,846,116.0000 | 95,215,322 | 0.38% | 0.05% |
| March 15, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 48295 | $9.14 | 12,846,116.0000 | 95,215,322 | 0.37% | 0.05% |
| March 14, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 239 | $9.00 | 12,894,577.0000 | 95,215,322 | 0.00% | 0.00% |
| March 14, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 205 | $9.00 | 12,894,411.0000 | 95,215,322 | 0.00% | 0.00% |
| March 13, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1300 | $9.00 | 12,894,816.0000 | 95,215,322 | 0.01% | 0.00% |
| March 13, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1500 | $9.00 | 12,894,616.0000 | 95,215,322 | 0.01% | 0.00% |
| Feb. 29, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 800 | $9.02 | 12,946,116.0000 | 95,215,322 | 0.01% | 0.00% |
| Feb. 29, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 1000 | $9.02 | 12,946,116.0000 | 95,215,322 | 0.01% | 0.00% |
| Feb. 29, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 1982 | $9.01 | 12,946,116.0000 | 95,215,322 | 0.02% | 0.00% |
| Feb. 29, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 800 | $9.02 | 12,946,116.0000 | 95,215,322 | 0.01% | 0.00% |
| Feb. 29, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1982 | $9.01 | 12,946,116.0000 | 95,215,322 | 0.02% | 0.00% |
| Feb. 29, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 1000 | $9.02 | 12,946,116.0000 | 95,215,322 | 0.01% | 0.00% |
| Feb. 28, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 25456 | $9.02 | 14,722,648.0000 | 95,215,322 | 0.17% | 0.03% |
| Feb. 26, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 100 | $9.01 | 14,722,648.0000 | 95,215,322 | 0.00% | 0.00% |
| Feb. 28, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 25456 | $9.02 | 14,722,648.0000 | 95,215,322 | 0.17% | 0.03% |
| Feb. 26, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 500 | $9.01 | 14,771,667.0000 | 95,215,322 | 0.00% | 0.00% |
| Feb. 28, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 24303 | $9.02 | 14,722,648.0000 | 95,215,322 | 0.16% | 0.03% |
| Feb. 26, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 100 | $9.01 | 14,722,648.0000 | 95,215,322 | 0.00% | 0.00% |
| Feb. 28, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 49019 | $9.02 | 14,722,648.0000 | 95,215,322 | 0.33% | 0.05% |
| Feb. 26, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 100 | $9.01 | 14,748,104.0000 | 95,215,322 | 0.00% | 0.00% |
| Feb. 26, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 500 | $9.01 | 14,771,667.0000 | 95,215,322 | 0.00% | 0.00% |
| Feb. 26, 2024 | Lowenthal Richard E | PRESIDENT AND CEO | S | Common Stock | 100 | $9.01 | 14,748,104.0000 | 95,215,322 | 0.00% | 0.00% |
| Feb. 28, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 24303 | $9.02 | 14,722,648.0000 | 95,215,322 | 0.16% | 0.03% |
| Feb. 28, 2024 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S | Common Stock | 49019 | $9.02 | 14,722,648.0000 | 95,215,322 | 0.33% | 0.05% |
| May 17, 2023 | Tanimoto Sarina | Chief Medical Officer | G | Common Stock | 1050000 | $0.00 | 11,999,376.0000 | 0 | 9.59% | 0.00% |
| May 17, 2023 | Lowenthal Richard E | President and CEO | G | Common Stock | 1050000 | $0.00 | 13,049,376.0000 | 0 | 7.45% | 0.00% |
| May 17, 2023 | Lowenthal Richard E | President and CEO | G | Common Stock | 1050000 | $0.00 | 11,999,376.0000 | 0 | 9.59% | 0.00% |
| May 17, 2023 | Lowenthal Richard E | President and CEO | G | Common Stock | 1050000 | $0.00 | 13,049,376.0000 | 0 | 7.45% | 0.00% |
| May 17, 2023 | Lowenthal Richard E | President and CEO | G | Common Stock | 1050000 | $0.00 | 13,049,376.0000 | 0 | 8.75% | 0.00% |
| Jan. 2, 2024 | Lowenthal Richard E | President and CEO | A | Stock option (right to buy) | 880000 | $0.00 | 1,180,000.0000 | 95,215,322 | 293.33% | 0.92% |
| Jan. 2, 2024 | Lowenthal Richard E | President and CEO | A | Stock option (right to buy) | 300000 | $0.00 | 1,180,000.0000 | 95,215,322 | 34.09% | 0.32% |
| Jan. 2, 2024 | Karas Eric | Chief Commercial Officer | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 95,215,322 | 9999.99% | 0.21% |
| May 17, 2023 | Tanimoto Sarina | Chief Medical Officer | G | Common Stock | 1050000 | $0.00 | 13,049,376.0000 | 0 | 7.45% | 0.00% |
| May 17, 2023 | Tanimoto Sarina | Chief Medical Officer | G | Common Stock | 1050000 | $0.00 | 13,049,376.0000 | 0 | 7.45% | 0.00% |
| May 17, 2023 | Tanimoto Sarina | Chief Medical Officer | G | Common Stock | 1050000 | $0.00 | 13,049,376.0000 | 0 | 8.75% | 0.00% |
| Jan. 2, 2024 | Tanimoto Sarina | Chief Medical Officer | A | Stock option (right to buy) | 300000 | $0.00 | 1,180,000.0000 | 95,215,322 | 34.09% | 0.32% |
| Jan. 2, 2024 | Tanimoto Sarina | Chief Medical Officer | A | Stock option (right to buy) | 880000 | $0.00 | 1,180,000.0000 | 95,215,322 | 293.33% | 0.92% |
| Jan. 2, 2024 | Dorsey Brian | Chief Operating Officer | A | Stock option (right to buy) | 350000 | $0.00 | 350,000.0000 | 95,215,322 | 9999.99% | 0.37% |
| Jan. 2, 2024 | Chakma Justin | Chief Business Officer | A | Stock option (right to buy) | 350000 | $0.00 | 350,000.0000 | 95,215,322 | 9999.99% | 0.37% |
| Jan. 2, 2024 | Scott Kathleen D. | Chief Financial Officer | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 95,215,322 | 9999.99% | 0.21% |
| Jan. 2, 2024 | Fitzpatrick Alexander A | Chief Legal Officer | A | Stock option (right to buy) | 300000 | $0.00 | 300,000.0000 | 95,215,322 | 9999.99% | 0.32% |
| Sept. 29, 2023 | Fitzpatrick Alexander A | Chief Legal Officer | P | Common Stock | 46258 | $3.78 | 89,227.0000 | 0 | 107.65% | 0.00% |
| Sept. 28, 2023 | Fitzpatrick Alexander A | Chief Legal Officer | P | Common Stock | 40000 | $3.62 | 42,969.0000 | 0 | 1347.26% | 0.00% |
| Sept. 21, 2023 | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 2508691 | $2.97 | 9,268,369.0000 | 0 | 37.11% | 0.00% |
| Sept. 21, 2023 | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 191309 | $3.83 | 9,459,678.0000 | 0 | 2.06% | 0.00% |
| Sept. 1, 2023 | Shawver Laura | Director | S | Common Stock | 100000 | $7.71 | 210,346.0000 | 0 | 32.22% | 0.00% |
| Sept. 1, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 2997 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 1, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 97003 | $0.00 | 55,235.0000 | 0 | 63.72% | 0.00% |
| Sept. 1, 2023 | Shawver Laura | Director | M | Common Stock | 2997 | $1.27 | 213,343.0000 | 0 | 1.42% | 0.00% |
| Sept. 1, 2023 | Shawver Laura | Director | M | Common Stock | 97003 | $1.27 | 310,346.0000 | 0 | 45.47% | 0.00% |
| Aug. 29, 2023 | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 3750000 | $6.20 | 6,759,678.0000 | 0 | 124.60% | 0.00% |
| Aug. 29, 2023 | Thompson Peter A. | Director | P | Common Stock | 500000 | $6.20 | 9,240,887.0000 | 0 | 5.72% | 0.00% |
| Aug. 29, 2023 | ORBIMED ADVISORS LLC | Director | P | Common Stock | 500000 | $6.20 | 9,240,887.0000 | 0 | 5.72% | 0.00% |
| Aug. 3, 2023 | Shawver Laura | Director | S | Common Stock | 26107 | $7.01 | 210,346.0000 | 0 | 11.04% | 0.00% |
| Aug. 4, 2023 | Shawver Laura | Director | M | Common Stock | 18897 | $1.27 | 229,243.0000 | 0 | 8.98% | 0.00% |
| Aug. 4, 2023 | Shawver Laura | Director | S | Common Stock | 18897 | $7.06 | 210,346.0000 | 0 | 8.24% | 0.00% |
| Aug. 3, 2023 | Shawver Laura | Director | M | Common Stock | 26107 | $1.27 | 236,453.0000 | 0 | 12.41% | 0.00% |
| Aug. 3, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 26017 | $0.00 | 21,894.0000 | 0 | 54.30% | 0.00% |
| Aug. 4, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 18897 | $0.00 | 2,997.0000 | 0 | 86.31% | 0.00% |
| Aug. 2, 2023 | Shawver Laura | Director | M | Common Stock | 36281 | $1.27 | 246,627.0000 | 0 | 17.25% | 0.00% |
| Aug. 1, 2023 | Shawver Laura | Director | M | Common Stock | 18715 | $1.27 | 229,061.0000 | 0 | 8.90% | 0.00% |
| Aug. 1, 2023 | Shawver Laura | Director | S | Common Stock | 18715 | $7.19 | 210,346.0000 | 0 | 8.17% | 0.00% |
| Aug. 2, 2023 | Shawver Laura | Director | S | Common Stock | 36281 | $7.09 | 210,346.0000 | 0 | 14.71% | 0.00% |
| Aug. 1, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 18715 | $0.00 | 84,282.0000 | 0 | 18.17% | 0.00% |
| Aug. 2, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 36281 | $0.00 | 48,001.0000 | 0 | 43.05% | 0.00% |
| July 7, 2023 | Shawver Laura | Director | M | Common Stock | 8858 | $1.27 | 219,204.0000 | 0 | 4.21% | 0.00% |
| July 7, 2023 | Shawver Laura | Director | S | Common Stock | 8858 | $6.36 | 210,346.0000 | 0 | 4.04% | 0.00% |
| July 7, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 8858 | $0.00 | 102,997.0000 | 0 | 7.92% | 0.00% |
| July 5, 2023 | Shawver Laura | Director | S | Common Stock | 31112 | $6.41 | 210,346.0000 | 0 | 12.89% | 0.00% |
| July 6, 2023 | Shawver Laura | Director | M | Common Stock | 33510 | $1.27 | 243,856.0000 | 0 | 15.93% | 0.00% |
| July 6, 2023 | Shawver Laura | Director | S | Common Stock | 33510 | $6.34 | 210,346.0000 | 0 | 13.74% | 0.00% |
| July 3, 2023 | Shawver Laura | Director | M | Common Stock | 26520 | $1.27 | 236,866.0000 | 0 | 12.61% | 0.00% |
| July 5, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 31112 | $0.00 | 145,365.0000 | 0 | 17.63% | 0.00% |
| July 6, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 33510 | $0.00 | 111,855.0000 | 0 | 23.05% | 0.00% |
| July 3, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 26520 | $0.00 | 176,477.0000 | 0 | 13.06% | 0.00% |
| July 3, 2023 | Shawver Laura | Director | S | Common Stock | 26520 | $6.73 | 210,346.0000 | 0 | 11.20% | 0.00% |
| July 5, 2023 | Shawver Laura | Director | M | Common Stock | 31112 | $1.27 | 241,458.0000 | 0 | 14.79% | 0.00% |
| June 27, 2023 | Dadoo Rajeev | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | RA CAPITAL MANAGEMENT, L.P. | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | Kelly Michael | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | Shah Pratik | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | Thompson Peter A. | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | Shawver Laura | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | SAUNDERS BRENT L | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | SCHNEIDER PHILLIP M | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | Islam Saqib | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 2, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 26941 | $0.00 | 202,997.0000 | 0 | 11.72% | 0.00% |
| June 1, 2023 | Shawver Laura | Director | M | Common Stock | 73059 | $1.27 | 283,405.0000 | 0 | 34.73% | 0.00% |
| June 1, 2023 | Shawver Laura | Director | S | Common Stock | 73059 | $6.80 | 210,346.0000 | 0 | 25.78% | 0.00% |
| June 2, 2023 | Shawver Laura | Director | M | Common Stock | 26941 | $1.27 | 237,287.0000 | 0 | 12.81% | 0.00% |
| June 2, 2023 | Shawver Laura | Director | S | Common Stock | 26941 | $6.95 | 210,346.0000 | 0 | 11.35% | 0.00% |
| June 1, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 73059 | $0.00 | 229,938.0000 | 0 | 24.11% | 0.00% |
| May 9, 2023 | Shawver Laura | Director | S | Common Stock | 42900 | $5.31 | 210,346.0000 | 0 | 16.94% | 0.00% |
| May 8, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 57100 | $0.00 | 345,897.0000 | 0 | 14.17% | 0.00% |
| May 9, 2023 | Shawver Laura | Director | M | Stock Option (Right to Buy) | 42900 | $0.00 | 302,997.0000 | 0 | 12.40% | 0.00% |
| May 9, 2023 | Shawver Laura | Director | M | Common Stock | 42900 | $1.27 | 253,246.0000 | 0 | 20.39% | 0.00% |
| May 8, 2023 | Shawver Laura | Director | S | Common Stock | 57100 | $6.16 | 210,346.0000 | 0 | 21.35% | 0.00% |
| May 8, 2023 | Shawver Laura | Director | M | Common Stock | 57100 | $1.27 | 267,446.0000 | 0 | 27.15% | 0.00% |
| Nov. 9, 2022 | Shawver Laura | Director | S | Common Stock | 43896 | $4.58 | 210,346.0000 | 0 | 17.27% | 0.00% |
| Jan. 3, 2023 | Chakma Justin | Chief Business Officer | A | Stock option (right to buy) | 165000 | $0.00 | 165,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Fitzpatrick Alexander A | Chief Legal Officer | A | Stock option (right to buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Scott Kathleen D. | Chief Financial Officer | A | Stock option (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Tanimoto Sarina | Chief Medical Officer | A | Stock option (right to buy) | 1100000 | $0.00 | 1,450,000.0000 | 0 | 314.29% | 0.00% |
| Jan. 3, 2023 | Lowenthal Richard E | President and CEO | A | Stock option (right to buy) | 1100000 | $0.00 | 1,450,000.0000 | 0 | 314.29% | 0.00% |
| Jan. 3, 2023 | Lowenthal Richard E | President and CEO | A | Stock option (right to buy) | 350000 | $0.00 | 1,450,000.0000 | 0 | 31.82% | 0.00% |
| Jan. 3, 2023 | Tanimoto Sarina | Chief Medical Officer | A | Stock option (right to buy) | 350000 | $0.00 | 1,450,000.0000 | 0 | 31.82% | 0.00% |
| Jan. 3, 2023 | Karas Eric | Chief Commercial Officer | A | Stock option (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Dorsey Brian | Chief Operating Officer | A | Stock option (right to buy) | 145000 | $0.00 | 145,000.0000 | 0 | 9999.99% | 0.00% |